Literature DB >> 22356144

Increased exhaled nitric oxide predicts new-onset rhinitis and persistent rhinitis in adolescents without allergic symptoms.

A Malinovschi1, K Alving, P Kalm-Stephens, C Janson, L Nordvall.   

Abstract

BACKGROUND: The fraction of nitric oxide in exhaled air (FE(NO)) is increased in rhinitis and asthma. We have previously suggested that elevated FE(NO) levels in the absence of asthma symptoms may be a sign of 'early asthma'. In the present study, we hypothesize that elevated exhaled NO levels may also precede rhinitis symptoms.
OBJECTIVE: To investigate in a cohort of adolescents whether or not increased exhaled NO levels at the age of 13-14 years predicted new-onset or persistent rhinitis within a 4-year period.
METHODS: A total of 959 randomly selected adolescents (13-14 years) completed a questionnaire on respiratory symptoms at baseline and follow-up, 4 years later. Exhaled NO was measured at baseline. After exclusion of subjects with asthma diagnosis or asthma symptoms at baseline, 657 participants were eligible for the present study.
RESULTS: Higher FE(NO) levels at baseline were associated with increased risk for new-onset (P = 0.009) and persistent rhinitis (P = 0.03) within a 4-year period. The risk of new-onset rhinitis was 2.32 (1.23, 4.37) [OR (95% CI)] times higher if FE(NO) > 90th percentile of the group without rhinitis at baseline. This increased risk for new-onset rhinitis was significant [2.49 (1.24, 5.01)] after excluding subjects with allergic symptoms. The risk of persistent rhinitis was 5.11 (1.34, 19.57) times higher if FE(NO) > 90th percentile of the group without rhinitis at baseline.
CONCLUSION: Elevated exhaled nitric oxide levels predicted incident and persistent rhinitis in this population-based study of adolescents. Moreover, these findings were consistent after excluding subjects with allergic symptoms. Thus, it appears that elevation of exhaled NO precedes airway symptoms and predicts development of rhinitis in subjects without allergic symptoms or family history of allergic disease.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356144     DOI: 10.1111/j.1365-2222.2011.03947.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  5 in total

Review 1.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

2.  Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?

Authors:  Ioana Adriana Muntean; Ioana Corina Bocsan; Stefan Vesa; Nicolae Miron; Irena Nedelea; Anca Dana Buzoianu; Diana Deleanu
Journal:  Medicina (Kaunas)       Date:  2020-05-14       Impact factor: 2.430

3.  Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research.

Authors:  Yoshiko Yoda; Naruhito Otani; Hideki Hasunuma; Hiroshi Kanegae; Masayuki Shima
Journal:  BMC Pulm Med       Date:  2012-11-02       Impact factor: 3.317

4.  Determinants of Children's Exhaled Nitric Oxide: New Insights from Quantile Regression.

Authors:  Yue Zhang; Kiros Berhane; Sandrah P Eckel; Muhammad T Salam; William S Linn; Edward B Rappaport; Theresa M Bastain; Frank D Gilliland
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

Review 5.  Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease.

Authors:  Hyo Bin Kim; Sandrah P Eckel; Jeong Hee Kim; Frank D Gilliland
Journal:  Allergy Asthma Immunol Res       Date:  2015-07-02       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.